Monthly implant of luteinizing hormone-releasing hormone agonist: a practical therapeutic approach for sex-steroid dependent gynecologic diseases
- 1 July 1987
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 48 (1) , 10-12
- https://doi.org/10.1016/s0015-0282(16)59281-4
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Shrinkage of uterine fibroids during therapy with goserelin (Zoladex ): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depotFertility and Sterility, 1987
- Toward Removing Uterine Fibroids without Surgery: Subcutaneous Infusion of a Luteinizing Hormone-Releasing Hormone Agonist Commencing in the Luteal PhaseJournal of Clinical Endocrinology & Metabolism, 1986
- Long-acting gonadotropin hormone-releasing hormone analogused to treat uteriFertility and Sterility, 1986
- Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot studyAmerican Journal of Obstetrics and Gynecology, 1985
- Suppression of Follicular Maturation by Infusion of a Luteinizing Hormone-Releasing Hormone Agonist Starting during the Late Luteal Phase in the Stumptailed Macaque MonkeyJournal of Clinical Endocrinology & Metabolism, 1985
- TREATMENT OF PATIENTS WITH ADVANCED CANCER OF THE PROSTATE USING A SLOW-RELEASE (DEPOT) FORMULATION OF THE LHRH AGONIST ICI 118630 (ZOLADEX®)Journal of Endocrinology, 1984
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984